Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evolutionary genomic perspective on preterm birth, genome editing, and pregnancy in the human species.

Frontiers in genome editing·2026
Same author

Longitudinal Analysis of Peripheral MicroRNA Expression and Depressive Symptom Severity Change in a Community Cohort.

Epigenomes·2026
Same author

Aberrant three-dimensional estimates of head motion and orientation are generated by the brain when the vestibular periphery is damaged.

Neuroscience·2026
Same author

Ontogenetic co-option of myotoxin expression variation in island Eastern Diamondback Rattlesnake (Crotalus adamanteus) venoms.

Toxicon : official journal of the International Society on Toxinology·2026
Same author

The relationship between social adversity, micro-RNA expression and post-traumatic stress in a prospective, community-based cohort.

Nature. Mental health·2026
Same author

Defining the human lung pathodegradome of the V8 protease from <i>Staphylococcus aureus</i>.

Infection and immunity·2026

Related Experiment Video

Updated: Jul 12, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
09:56

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

16.3K

Restriction Checkpoint Controls Bradyzoite Development in Toxoplasma gondii.

Anatoli V Naumov1, Chengqi Wang2, Dale Chaput3

  • 1Department of Internal Medicine, Division of Infectious Diseases and International Medicine, Morsani College of Medicine, University of South Floridagrid.170693.a, Tampa, Florida, USA.

Microbiology Spectrum
|June 2, 2022
PubMed
Summary

Researchers discovered a cell cycle switch in Toxoplasma gondii, controlled by atypical cyclins, that regulates the transition between rapid growth and chronic infection stages. This finding offers new drug targets against this human pathogen.

Keywords:
Toxoplasma gondiiapicomplexanbradyzoitecyclincyclin-dependent kinasedevelopment

More Related Videos

Genetic Manipulation in &Delta;ku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
09:52

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii

Published on: July 12, 2013

17.2K
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

11.2K

Related Experiment Videos

Last Updated: Jul 12, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions
09:56

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

16.3K
Genetic Manipulation in &Delta;ku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
09:52

Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii

Published on: July 12, 2013

17.2K
Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

11.2K

Area of Science:

  • Parasitology
  • Cell Biology
  • Molecular Biology

Background:

  • Toxoplasma gondii causes human toxoplasmosis, with tachyzoites driving acute disease and bradyzoites causing chronic infections.
  • Understanding the parasite's cell cycle control is crucial for developing new therapies against chronic and drug-resistant stages.

Purpose of the Study:

  • To identify the cell cycle mechanism regulating the switch between Toxoplasma gondii growth and differentiation.
  • To characterize the roles of specific cyclins in parasite development and replication.

Main Methods:

  • Investigated the G1 restriction checkpoint (R-point) in T. gondii.
  • Utilized conditional knockdown models and gene expression analyses.
  • Examined cyclin-TgCycP1, TgCycP2, and TgCyc5 interactions with TgCrk2 kinase.

Main Results:

  • Identified a T. gondii R-point network involving TgCrk2 kinase and atypical cyclins (TgCycP1, TgCycP2, TgCyc5).
  • TgCycP1 promotes rapid RH tachyzoite growth and inhibits differentiation.
  • TgCycP2 regulates G1 duration in ME49 tachyzoites and bradyzoite replication; TgCyc5 is vital for tissue cyst maturation.

Conclusions:

  • The T. gondii R-point network, composed of TgCrk2 and atypical cyclins, controls parasite growth and differentiation.
  • TgCycP1, TgCycP2, and TgCyc5 have distinct roles in parasite development.
  • This parasite-specific network presents potential drug targets for treating toxoplasmosis.